Hypersensitivity reaction in the US Food and Drug Administration-approved second-generation drug-eluting stents histopathological assessment with Ex vivo optical coherence tomography

Circulation

Volumn 131, Issue 3, 2015, Pages 322-324

  Otsuka, Fumiyuki ^a   Yahagi, Kazuyuki ^a   Ladich, Elena ^a   Kutys, Robert ^a   Alexander, Russell ^b   Fowler, David ^b   Virmani, Renu ^a   Joner, Michael ^a  

^a CVPATH INSTITUTE   (United States)

^b OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS; RAPAMYCIN;

ADULT; ALLERGIC REACTION; CASE REPORT; DRUG ELUTING CORONARY STENT; EX VIVO STUDY; FOOD AND DRUG ADMINISTRATION; HISTOPATHOLOGY; HUMAN; MALE; MIDDLE AGED; NOTE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED STATES; UNSTABLE ANGINA PECTORIS; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; LEGISLATION AND JURISPRUDENCE; PROCEDURES;

DRUG HYPERSENSITIVITY; DRUG-ELUTING STENTS; HUMANS; MALE; MIDDLE AGED; SIROLIMUS; TOMOGRAPHY, OPTICAL COHERENCE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84925282744     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.012658     Document Type: Note

References (4)

1. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-705. doi: 10.1161/01.CIR.0000116202.41966.D4.
2. Tada T, Kadota K, Hosogi S, Kubo S, Ozaki M, Yoshino M, Miyake K, Eguchi H, Ohashi N, Hayakawa Y, Saito N, Otsuru S, Hasegawa D, Shigemoto Y, Habara S, Imai M, Tanaka H, Fuku Y, Oka N, Kato H, Yamamoto H, Fujii S, Goto T, Mitsudo K. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Circ Cardiovasc Interv. 2012;5:649-656. doi: 10.1161/CIRCINTERVENTIONS.112.968487.
3. Shin HW, Nam CW, Kim H, Hur SH, Kim YN, Kim KB, Kwon KY. Zotarolimus-eluting stent-induced hypersensitivity pneumonitis. Korean J Intern Med. 2013;28:108-111. doi: 10.3904/kjim.2013.28.1.108.
4. Buhaescu I, Izzedine H, Covic A. Sirolimus: challenging current perspectives. Ther Drug Monit. 2006;28:577-584. doi: 10.1097/01. ftd.0000245377.93401.39.